Jordan A. J. McCone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jordan A. J. McCone has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Anindita Sen
The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington Wellington, New Zealand; School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington, New Zealand
1 shared publication- Bernhard V. K. J. Schmidt
School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK
1 shared publication - Cameron Jones
School of Chemistry, Monash University, PO Box 23, VIC, 3800, Australia
1 shared publication Clement Sester
The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington Wellington, New Zealand; School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington, New Zealand
1 shared publication- Frederik Roman Wurm
Sustainable Polymer Chemistry Department of Molecules and Materials MESA+ Institute for Nanotechnology Faculty of Science and Technology Universiteit Twente PO Box 217 Enschede 7500 AE The Netherlands
1 shared publication - Georgia M. Richardson
School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington, New Zealand
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (10) , 5220-5228
Degradable polyphosphoester-based aqueous two-phase systems and water-in-water emulsions
New aqueous two-phase systems and water-in-water emulsions are described that feature triggered degradation.
- 9 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (10) , 5220-5228
Open AccessDegradable polyphosphoester-based aqueous two-phase systems and water-in-water emulsions
New aqueous two-phase systems and water-in-water emulsions are described that feature triggered degradation.
- Open Access
- 31 May 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (35) , e202401051
A Structure‐Activity Investigation of the Fungal Metabolite (−)‐TAN‐2483B: Inhibition of Bruton's Tyrosine Kinase
The natural product (−)‐TAN‐2483B is a fungal secondary metabolite which displays promising anti‐cancer and immunomodulatory activity. Our previous syntheses of (−)‐TAN‐2483B and sidechain analogues uncovered inhibitory activity against Bruton's tyrosine kinase (Btk), an established drug target for various leukaemia and immunological diseases. A structure‐based computational study using ensemble docking and molecular dynamics was performed to determine plausible binding modes for (−)‐TAN‐2483B and analogues in the Btk binding site. These hypotheses guided the design of new analogues which were synthesised and their inhibitory activities determined, providing insights into the structural determinants of the furopyranone scaffold that confer both activity and selectivity for Btk. These findings offer new perspectives for generating optimised (−)‐TAN‐2483B‐based kinase inhibitors for the treatment of leukaemia and immunological diseases.
- 31 May 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (35) , e202401051
Open AccessA Structure‐Activity Investigation of the Fungal Metabolite (−)‐TAN‐2483B: Inhibition of Bruton's Tyrosine Kinase
The natural product (−)‐TAN‐2483B is a fungal secondary metabolite which displays promising anti‐cancer and immunomodulatory activity. Our previous syntheses of (−)‐TAN‐2483B and sidechain analogues uncovered inhibitory activity against Bruton's tyrosine kinase (Btk), an established drug target for various leukaemia and immunological diseases. A structure‐based computational study using ensemble docking and molecular dynamics was performed to determine plausible binding modes for (−)‐TAN‐2483B and analogues in the Btk binding site. These hypotheses guided the design of new analogues which were synthesised and their inhibitory activities determined, providing insights into the structural determinants of the furopyranone scaffold that confer both activity and selectivity for Btk. These findings offer new perspectives for generating optimised (−)‐TAN‐2483B‐based kinase inhibitors for the treatment of leukaemia and immunological diseases.
- Open Access
- 8 April 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (27) , e202400681
Synthesis and Reactivity of Discrete Europium(II) Hydride Complexes
The bulky β‐diketiminate ligand frameworks [BDIDCHP]− and [BDIDipp/Ar]− (BDI=[HC{C(Me)2N‐Dipp/Ar}2]− (Dipp=2,6‐diisopropylphenyl (Dipp); Ar=2,6‐dicyclohexylphyenyl (DCHP) or 2,4,6‐tricyclohexylphyenyl (TCHP)) have been developed for the kinetic stabilisation of the first europium (II) hydride complexes, [(BDIDCHP)Eu(μ‐H)]2, [(BDIDipp/DCHP)Eu(μ‐H)]2 and [(BDIDipp/TCHP)Eu(μ‐H)]2, respectively. These complexes represent the first step beyond the current lanthanide(II) hydrides that are all based on ytterbium. Tuning the steric profile of β‐diketiminate ligands from a symmetrical to unsymmetrical disposition, enhanced solubility and stability in the solution–state. This provides the first opportunity to study the structure and bonding of these novel Eu(II) hydride complexes crystallographically, spectroscopically and computationally, with their preliminary reactivity investigated.
- 8 April 2024
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (27) , e202400681
Open AccessSynthesis and Reactivity of Discrete Europium(II) Hydride Complexes
The bulky β‐diketiminate ligand frameworks [BDIDCHP]− and [BDIDipp/Ar]− (BDI=[HC{C(Me)2N‐Dipp/Ar}2]− (Dipp=2,6‐diisopropylphenyl (Dipp); Ar=2,6‐dicyclohexylphyenyl (DCHP) or 2,4,6‐tricyclohexylphyenyl (TCHP)) have been developed for the kinetic stabilisation of the first europium (II) hydride complexes, [(BDIDCHP)Eu(μ‐H)]2, [(BDIDipp/DCHP)Eu(μ‐H)]2 and [(BDIDipp/TCHP)Eu(μ‐H)]2, respectively. These complexes represent the first step beyond the current lanthanide(II) hydrides that are all based on ytterbium. Tuning the steric profile of β‐diketiminate ligands from a symmetrical to unsymmetrical disposition, enhanced solubility and stability in the solution–state. This provides the first opportunity to study the structure and bonding of these novel Eu(II) hydride complexes crystallographically, spectroscopically and computationally, with their preliminary reactivity investigated.
- 26 April 2022
- Published by Elsevier in Biophysical Journal
- Vol. 121 (11) , 2193-2205
Unraveling the binding mode of a methamphetamine aptamer: A spectroscopic and calorimetric study
- 26 April 2022
- Published by Elsevier in Biophysical Journal
- Vol. 121 (11) , 2193-2205
Unraveling the binding mode of a methamphetamine aptamer: A spectroscopic and calorimetric study